PROBE was delighted to host a pre-congress workshop at this year’s OARSI - Osteoarthritis Research Society International World Congress to showcase how federated data access can revolutionize OA research. This session, led by PROBE’s academic and industrial co-leads, Erasmus MC and Novartis, explored how cross-institutional collaboration and multimodal data sharing can accelerate breakthroughs: IHI PROBE: [...]

Jos Runhaar (Erasmus MC) was invited to present PROBE’s vision for privacy-preserving, multi-modal OA research at the 20th International Workshop for Osteoarthritis Investigation (IWOAI).  The PROBE consortium headed to IWOAI 2026 to share how federated data networks and AI-driven analytics can accelerate breakthroughs in osteoarthritis (OA) research, clinical trials, and patient care. In Session 3 on [...]

Osteoarthritis (OA) is a complex, multifactorial disease influenced by genetic, environmental, and biomechanical factors. To advance personalized treatment strategies, the PROBE consortium’s team, led by Helmholtz Munich, has conducted a comprehensive review of the latest genetic research in OA, now published in Osteoarthritis and Cartilage. This review lays the foundation for PROBE’s work in: Identifying [...]

The PROBE consortium officially kicked off its groundbreaking initiative with a two-day meeting in Rotterdam on January 12-13, 2026. The event brought together leading academic institutions, industry partners, and stakeholders to align on the project’s vision: transforming osteoarthritis (OA) treatment through federated big data, AI-driven innovation, and patient-centered clinical strategies. The meeting began with welcoming [...]